Lyra Therapeutics Stock (NASDAQ: LYRA) stock price, news, charts, stock research, profile.
Open | $0.380 |
Close | $0.373 |
Volume / Avg. | 3.680M / 2.621M |
Day Range | 0.356 - 0.385 |
52 Wk Range | 0.360 - 6.790 |
Market Cap | $22.837M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 13 |
Short Interest | 0.7% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Lyra Therapeutics (NASDAQ: LYRA) through any online brokerage.
Other companies in Lyra Therapeutics’s space includes: Cumberland (NASDAQ:CPIX), Iterum Therapeutics (NASDAQ:ITRM), Cocrystal Pharma (NASDAQ:COCP), Kiora Pharmaceuticals (NASDAQ:KPRX) and Universe Pharmaceuticals (NASDAQ:UPC).
The latest price target for Lyra Therapeutics (NASDAQ: LYRA) was reported by HC Wainwright & Co. on Tuesday, May 7, 2024. The analyst firm set a price target for 2.00 expecting LYRA to rise to within 12 months (a possible 433.90% upside). 10 analyst firms have reported ratings in the last year.
The stock price for Lyra Therapeutics (NASDAQ: LYRA) is $0.3746 last updated May 10, 2024 at 7:59 PM EDT.
There are no upcoming dividends for Lyra Therapeutics.
Lyra Therapeutics’s Q2 earnings are confirmed for Tuesday, August 6, 2024.
There is no upcoming split for Lyra Therapeutics.
Lyra Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.